Bausch + Lomb Corporation (BLCO) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bausch + Lomb Corporation has launched INFUSE for Astigmatism, a new daily disposable contact lens for astigmatism sufferers in the U.S., featuring innovative ProBalance Technology™ and OpticAlign® design for all-day comfort and clear vision. The lenses offer unique properties such as high moisture content and breathability, and are designed to reduce common issues such as lens dryness and rotation. With promising initial study results and a wide range of in-office parameters, INFUSE for Astigmatism aims to meet the demand for performance and comfort in modern lifestyles.
For further insights into BLCO stock, check out TipRanks’ Stock Analysis page.